在法布里病中,GLA突变抑制了自并刺激了溶酶体的产生
Ping Li1, Yuqian Xi1, Yanping Zhang1
1Institutes of Biomedical Sciences, The Key Laboratory of Chemical Biology and Molecular Engineering of Ministry of Education of China, The Key Laboratory of Medical Molecular Cell Biology of Shanxi Province, Shanxi University, Taiyuan 030006, China.
Cells
|March 13, 2024
概括
四个法布里病 (FD) 的α-galactosidase A (α-Gal A) 突变损害了酶功能和自. 这项研究阐明了这些GLA突变的分子机制,有助于FD的诊断和治疗.
科学领域:
- 生物化学 生物化学
- 遗传学 是一个遗传学.
- 细胞生物学 细胞生物学
背景情况:
- 法布里病 (FD) 是一种由*GLA*基因的致病突变引起的溶酶体储存障碍,导致阿尔法-银酸酶A (α-Gal A) 缺乏.
- FD会影响多个器官系统,包括脏,心脏和中枢神经系统.
- 四种特定的*GLA*突变 (c.119C>A,c.280T>C,c.680G>C,c.801+1G>A) 之前在FD家族中被确定.
研究的目的:
- 调查四种已识别的*GLA*突变的致病性背后的分子机制.
- 分析这些突变对α-Gal A酶的结构和功能的影响.
- 阐明这些*GLA*突变的细胞后果,包括对自和溶酶体生物发生的影响.
主要方法:
- 对四种*GLA*突变对α-Gal A蛋白质结构的影响的生物信息分析.
- 对已识别的GLA突变体的酶活性评估.
- 细胞研究以评估自细胞积累,自细胞功能障碍,mTOR酸化和LAMP2表达.
主要成果:
- 这四种*GLA*突变显著改变了位于酶活性部位附近的α-Gal A的内部动力学和结构.
- 这些突变导致α-Gal A酶活性大幅降低.
- 突变的GLA表达导致自细胞积累,自细胞功能受损,mTOR酸化增加,并且由于LAMP2表达增加, lysosomes的数量增加.
结论:
- 研究的*GLA*突变通过破坏α-Gal A酶功能和细胞自途径导致法布里病.
- 这些发现为了解与这些特定突变相关的FD病原体提供了分子基础.
- 这项研究支持改善Fabry病的诊断准确性和有针对性的治疗策略.
相关概念视频
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Delivery Pathways to the Lysosome
6.5K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.5K
Autophagy
4.2K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.2K
Autophagic Cell Death
3.4K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.4K
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K


